The U.S. Court of Appeals for the Federal Circuit has stepped into the debate over tribal sovereign immunity at the Patent Trial and Appeal Board.

The D.C.-based appellate court on Wednesday stopped a PTAB proceeding in which the board has declined to recognize the Saint Regis Mohawk Tribe’s sovereign immunity. The Federal Circuit scheduled a June hearing on the tribe’s bid to dismiss the proceedings, in which generic pharmaceutical companies challenge the validity of patents on Allergan’s Restasis dry eye medication.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]